ロード中...
Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
INTRODUCTION: Alemtuzumab and rabbit antithymocyte globulin (rATG) are being used with increasing frequency as induction agents in kidney transplantation. Using the US Renal Data Base System, we analyzed the safety profile of these agents in the elderly. METHODS: In a cohort of patients transplanted...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3237278/ https://ncbi.nlm.nih.gov/pubmed/22104284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000334092 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|